Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.

Thierry BrueAnders LindbergAart Jan van der LelyAnn Charlotte AkerbladMaria Koltowska-HäggströmRoy GomezMichael DrosteJudith Hey-HadaviChristian J StrasburgerCecilia Camacho-Hübner

Published in: Endocrine (2018)

Patients with DM had a moderate decrease in mean fasting glucose values during PEGV treatment.

Keyphrases

blood glucose
glycemic control
type diabetes
cardiovascular disease
insulin resistance
high intensity
adipose tissue
combination therapy
newly diagnosed
weight loss